Predicted protein targets (top 10)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | KMT2A | Q03164 | 2/20 | 0.38 |
| ▸ | CNR2 | P34972 | 4/20 | 0.38 |
| ▸ | TSHR | P16473 | 1/20 | 0.37 |
| ▸ | MAPK14 | Q16539 | 6/20 | 0.37 |
| ▸ | SMO | Q99835 | 6/20 | 0.37 |
| ▸ | TYK2 | P29597 | 1/20 | 0.36 |
| ▸ | JAK3 | P52333 | 1/20 | 0.36 |
| ▸ | BTK | Q06187 | 1/20 | 0.35 |
| ▸ | PDCD1 | Q15116 | 1/20 | 0.35 |
| ▸ | CD274 | Q9NZQ7 | 1/20 | 0.35 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL21617236 | 1.00 | KMT2A (0.38) | KMT2ACNR2TSHRMAPK14SMO | |
| SCHEMBL23308002 | 0.87 | TYK2 (0.39) | KMT2ACNR2MAPK14SMOTYK2 | |
| SCHEMBL21623401 | 0.86 | CNR2 (0.40) | KMT2ACNR2TSHRMAPK14SMO | |
| SCHEMBL31504348 | 0.86 | CNR2 (0.40) | KMT2ACNR2TSHRMAPK14SMO | |
| SCHEMBL23308003 | 0.80 | CNR2 (0.39) | KMT2ACNR2MAPK14SMOTYK2 | |
| SCHEMBL21617197 | 0.79 | CTSK (0.40) | KMT2ACNR2MAPK14SMOTYK2 | |
| SCHEMBL31504434 | 0.79 | CTSK (0.40) | KMT2ACNR2MAPK14SMOTYK2 | |
| SCHEMBL23307996 | 0.78 | PDCD1 (0.33) | BTKPDCD1CD274 | |
| SCHEMBL21623470 | 0.77 | CNR2 (0.40) | KMT2ACNR2MAPK14SMOTYK2 | |
| SCHEMBL31504445 | 0.77 | CNR2 (0.40) | KMT2ACNR2MAPK14SMOTYK2 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| EP-3820850-B1 | PHENYL/PYRIDYL-N-PHENYL/PYRIDYL DERIVATIVES FOR TREATING A RNA VIRUS INFECTION | ABIVAX (FR) | 2026-04-01 | — | — | EP | disclosed |
| CN-112638877-B | Phenyl/pyridinyl-N-phenyl/pyridinyl derivatives for the treatment of RNA viral infections | ABIVAX公司 | 2025-04-22 | — | — | CN | disclosed |